Wishing you all the joys of the season! 
Asia Pacific Microcarriers Market Forecast to 2030
Asia Pacific Microcarriers Market Forecast to 2030 – Regional Analysis – by Product (Media & Reagents and Microcarrier Beads), Equipment (Bioreactors, Culture Vessels, and Others), Application (Biopharmaceutical Production, Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, and Academic & Research Institutes)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Surge in Adoption of Regenerative Medicine Fuels Asia Pacific Microcarriers Market
The rising adoption of regenerative medicine has emerged as a significant driver propelling the growth of the microcarriers market. Regenerative medicine focuses on repairing, replacing, or regenerating damaged tissues and organs, making it a promising field for addressing various medical conditions. Microcarriers play a pivotal role in the cultivation and expansion of cells, a fundamental aspect of regenerative medicine.
In regenerative medicine, cells are cultured outside the body before being transplanted, and microcarriers provide a suitable environment for cell attachment, proliferation, and differentiation. They serve as a substrate for cell growth in bioreactors, facilitating the efficient production of large quantities of cells. This is particularly crucial for regenerative therapies, where a substantial number of viable and functional cells are needed.
Moreover, microcarriers enhance the scalability and cost-effectiveness of cell processes, addressing key challenges in the translation of regenerative medicine from research to clinical applications. As the regenerative medicine field continues to advance, with an increasing focus on stem cell therapies and tissue engineering, the demand for microcarriers is expected to escalate, driving innovation and expansion within the microcarriers market
Asia Pacific Microcarriers Market Overview
The microcarrier market in Asia Pacific is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific countries. Several countries in Asia Pacific invest significantly in cell and gene therapy R&D. China, India, and Japan are the three major contributors to the growth of the microcarriers market in this region, and the market growth can be attributed to the growing emphasis of businesses on cost optimization, burgeoning efforts to streamline clinical processes, supportive government policies, and increasing number of clinical trials. The government of the People’s Republic of China is focused on improving public health, providing cost-effective public health programs, expanding the coverage of health-related financial protection measures, and investing in a vast healthcare delivery network. The 13th Chinese plan expected a more than 4% contribution of the biotechnology industry to the GDP in 2020, which would be nearly 10-20 life-science parities. More than 100 life-science parks controlled by local governments are functional across China, and these centers entice enterprises with tax advantages and subsidies. State, provincial, and local governments are reported to have already invested more than US$ 100 billion in the biosciences sector to meet the goals of the five-year plan of China. In 2003, it became the first country to approve a gene therapy, and since then, the development of cell and gene therapies with elevated therapeutic potential has picked pace worldwide. According to a study published in Nature in 2021, China is home to more than 50% of all cell therapy trials across the world. The country currently has nearly 400 ongoing CAR-T trials centered on hematology, and oncology and solid tumors. In 2021, the National Medical Products Administration (NMPA) approved Fosun Kite’s Yescarta and JW Therapeutics’ Relma-cel, with which cell therapies in China entered a new era.
Asia Pacific Microcarriers Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Microcarriers Market Segmentation
The Asia Pacific microcarriers market is segmented into product, equipment, application, end user, and country.
Based on product, the Asia Pacific microcarriers market is bifurcated into microcarriers beads and media & reagents. The microcarriers beads segment held a larger share of the Asia Pacific microcarriers market in 2022.
In terms of equipment, the Asia Pacific microcarriers market is segmented into bioreactors, culture vessels, and others. The bioreactors segment held the largest share of the Asia Pacific microcarriers market in 2022.
Based on application, the Asia Pacific microcarriers market is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and other. The biopharmaceutical production segment held the largest share of the Asia Pacific microcarriers market in 2022. Further, biopharmaceutical production segment is categorized into therapeutic protein production and vaccine production.
Based on end user, the Asia Pacific microcarriers market is segmented into pharmaceutical & biotechnology companies, contract research organizations & contract manufacturing organizations, and academic & research institutes. The pharmaceutical & biotechnology companies segment held the largest share of the Asia Pacific microcarriers market in 2022.
Based on country, the Asia Pacific microcarriers market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific microcarriers market in 2022.
Teijin Ltd, Bio-Rad Laboratories Inc, Sartorius AG, Danaher Corp, Corning Inc, Eppendorf SE, Asahi Kasei Corp, and Polysciences Inc are some of the leading companies operating in the Asia Pacific microcarriers market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team research, the Asia Pacific microcarriers market was valued at US$ 366.14 million in 2022 and is expected to reach US$ 991.23 million by 2030, registering a CAGR of 13.3% from 2022 to 2030. Strategic initiatives and innovative products by microcarrier manufacturers and infectious diseases and increasing popularity of outsourcing cell and gene therapy manufacturing are among the critical factors attributed to the Asia Pacific microcarriers market expansion.
Companies operating in the microcarriers market focus on strategic developments such as collaborations, expansions, agreements, partnerships, and new product launches, which help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a larger than existing customer base. A few of the noteworthy developments in the microcarriers market are mentioned, In October 2023, Kuraray Co., Ltd. developed PVA hydrogel microcarriers for cell cultures used in regenerative medicine. The product is scheduled for launch in January 2024 in Japan and overseas, beginning in the US. In June 2023, Teijin Frontier introduced new nonwoven microcarriers that enable speedy, large-scale, high-quality cell culture. The new nonwoven microcarriers combine Teijin Frontier’s proprietary fiber process and nonwoven design technology, and fiber-related biomedical expertise by the Faculty of Engineering, University of Fukui, Japan. In October 2023, Semarion, unveiled the Early Adopter Programme for its SemaCyte Microcarrier Platform. SemaCytes developed by Semarion are cell carrier materials created using microchip fabrication technologies, nanomagnetism, and smart materials. These assaying microcarriers are flat and function as ultraminiaturized, magnetically steerable wells that carry small colonies of adherent cells into suspension to improve cell-based experiments. In November 2020, researchers from the Singapore-MIT Alliance for Science and Technology (SMART) developed a novel microcarrier for large-scale cell production and cell expansion. Employing this microcarrier would allow businesses to have higher yields in a more cost-effective way than traditional methods while lowering the number of steps involved in the cell retrieval process. This newly developed dissolvable Gelatin microcarrier from SMART can be used in cell expansion for treating various ailments, including bone and cartilage defects, and graft vs. host disease, i.e., the rejection of foreign bone marrow and cells. Therefore, introducing products such as PVA hydrogel microcarriers, nonwoven microcarriers, and SemaCyte microcarrier platform, and the initiation of new businesses through collaborations and partnerships to remain competitive in the market would create significant growth opportunities in the microcarriers market.
On the contrary, high cost of biologics and cell-based therapies hampers the Asia Pacific microcarriers market.
Based on product, the Asia Pacific microcarriers market is bifurcated into microcarriers beads and media & reagents. The microcarriers beads segment held 67.0% share of Asia Pacific microcarriers market in 2022, amassing US$ 245.48 million. It is projected to garner US$ 676.82 million by 2030 to expand at 13.5% CAGR during 2022-2030.
In terms of equipment, the Asia Pacific microcarriers market is categorized into bioreactors, culture vessels, and others. The bioreactors segment held 65.9% share of Asia Pacific microcarriers market in 2022, amassing US$ 241.46 million. It is projected to garner US$ 666.82 million by 2030 to expand at 13.5% CAGR during 2022-2030.
Based on application, the Asia Pacific microcarriers market is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and other. The biopharmaceutical production beads segment held 51.9% share of Asia Pacific microcarriers market in 2022, amassing US$ 189.92 million. It is projected to garner US$ 534.02 million by 2030 to expand at 13.8% CAGR during 2022-2030. Further, biopharmaceutical production segment is categorized into therapeutic protein production and vaccine production.
Based on end user, the Asia Pacific microcarriers market is segmented into pharmaceutical & biotechnology companies, contract research organizations & contract manufacturing organizations, and academic & research institutes. The pharmaceutical & biotechnology companies segment held 55.7% share of Asia Pacific microcarriers market in 2022, amassing US$ 203.93 million. It is projected to garner US$ 565.52 million by 2030 to expand at 13.6% CAGR during 2022-2030.
By country, the Asia Pacific microcarriers market has been categorized into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. Our regional analysis states that China captured 36.6% share of Asia Pacific microcarriers market in 2022. It was assessed at US$ 134.12 million in 2022 and is likely to hit US$ 367.05 million by 2030, exhibiting a CAGR of 13.4% during 2022-2030.
Key players operating in the Asia Pacific microcarriers market are Teijin Ltd, Bio-Rad Laboratories Inc, Sartorius AG, Danaher Corp, Corning Inc, Eppendorf SE, Asahi Kasei Corp, and Polysciences Inc, among others.
In June 2023, Teijin Ltd introduced the new nonwoven microcarriers for speedy and large-scale cell culture. This scaffolding substance promotes three-dimensional adhesion and growth for a variety of cell types.
In May 2022, Saint-Gobain Life Sciences released beadMATRIX for mesenchymal stromal cells (MSCs). beadMATRIX are ready-to-use, pre-coated microcarriers free of animal components that are used to cultivate superior MSCs in vitro. Shaker bags, stirred tanks, vertical wheel bioreactors, and shaker flasks are the perfect environments for beadMATRIX
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific microcarriers market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TABLE OF CONTENTS
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Microcarriers Market – Key Industry Dynamics
4.1 Key Market Drivers:
4.1.1 Need for Cell Therapies with Rising Incidence of Cancer and Infectious Diseases
4.1.2 Increasing Popularity of Outsourcing Cell and Gene Therapy Manufacturing
4.1.3 Surge in Adoption of Regenerative Medicine
4.2 Market Restraints
4.2.1 High Cost of Biologics and Cell-based Therapies
4.3 Market Opportunities
4.3.1 Strategic Initiatives and Innovative Products by Microcarrier Manufacturers
4.4 Future Trends
4.4.1 Automation of Cell and Gene Therapy Manufacturing Services
4.5 Impact Analysis
5. Microcarriers Market – Asia Pacific Market Analysis
5.1 Microcarriers Market Revenue (US$ Mn), 2022 – 2030
6. Asia Pacific Microcarriers Market – Revenue and Forecast to 2030 – by Product
6.1 Overview
6.2 Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Microcarrier Beads
6.3.1 Overview
6.3.2 Microcarrier Beads: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Media and Reagents
6.4.1 Overview
6.4.2 Media and Reagents: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Microcarriers Market – Revenue and Forecast to 2030 – by Equipment
7.1 Overview
7.2 Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
7.3 Bioreactors
7.3.1 Overview
7.3.2 Bioreactors: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Culture Vessels
7.4.1 Overview
7.4.2 Culture Vessels: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Microcarriers Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Biopharmaceutical Production
8.3.1 Overview
8.3.2 Biopharmaceutical Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
8.3.3 Therapeutic Protein Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
8.3.4 Vaccine Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Cell and Gene Therapy
8.4.1 Overview
8.4.2 Cell and Gene Therapy: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Tissue Engineering and Regenerative Medicine
8.5.1 Overview
8.5.2 Tissue Engineering and Regenerative Medicine: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Microcarriers Market Revenue and Forecasts To 2030 – End User
9.1 Overview
9.2 Asia Pacific Microcarriers Market Share by End User – 2022 & 2030 (%)
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Overview
9.3.2 Pharmaceutical and Biotechnology Companies: Microcarriers Market- Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Research Organizations and Contract Manufacturing Organizations
9.4.1 Overview
9.4.2 Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)
10. Asia Pacific Microcarriers Market Revenue and Forecasts to 2030 – Country Analysis
10.1 Asia Pacific Microcarriers Market, Revenue and Forecast To 2030
10.1.1 Overview
10.1.2 Asia Pacific: Microcarriers Market, by Country
10.1.2.1 China
10.1.2.1.1 Overview
10.1.2.1.2 China: Microcarriers Market Revenue and Forecast to 2030 (CHINA$ Mn)
10.1.2.1.3 China: Microcarriers Market, by Product
10.1.2.1.4 China: Microcarriers Market, by Equipment
10.1.2.1.5 China: Microcarriers Market, by Application
10.1.2.1.5.1 China: Microcarriers Market, by Biopharmaceutical Production
10.1.2.1.6 China: Microcarriers Market, by End User
10.1.2.2 Japan
10.1.2.2.1 Overview
10.1.2.2.2 Japan: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.2.3 Japan: Microcarriers Market, by Product
10.1.2.2.4 Japan: Microcarriers Market, by Equipment
10.1.2.2.5 Japan: Microcarriers Market, by Application
10.1.2.2.5.1 Japan: Microcarriers Market, by Biopharmaceutical Production
10.1.2.2.6 Japan: Microcarriers Market, by End User
10.1.2.3 India
10.1.2.3.1 Overview
10.1.2.3.2 India: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.3.3 India: Microcarriers Market, by Product
10.1.2.3.4 India: Microcarriers Market, by Equipment
10.1.2.3.5 India: Microcarriers Market, by Application
10.1.2.3.5.1 India: Microcarriers Market, by Biopharmaceutical Production
10.1.2.3.6 India: Microcarriers Market, by End User
10.1.2.4 Australia
10.1.2.4.1 Overview
10.1.2.4.2 Australia: Microcarriers Market Revenue and Forecast to 2030 (AUSTRALIA$ Mn)
10.1.2.4.3 Australia: Microcarriers Market, by Product
10.1.2.4.4 Australia: Microcarriers Market, by Equipment
10.1.2.4.5 Australia: Microcarriers Market, by Application
10.1.2.4.5.1 Australia: Microcarriers Market, by Biopharmaceutical Production
10.1.2.4.6 Australia: Microcarriers Market, by End User
10.1.2.5 South Korea
10.1.2.5.1 Overview
10.1.2.5.2 South Korea: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.5.3 South Korea: Microcarriers Market, by Product
10.1.2.5.4 South Korea: Microcarriers Market, by Equipment
10.1.2.5.5 South Korea: Microcarriers Market, by Application
10.1.2.5.5.1 South Korea: Microcarriers Market, by Biopharmaceutical Production
10.1.2.5.6 South Korea: Microcarriers Market, by End User
10.1.2.6 Rest of Asia Pacific
10.1.2.6.1 Overview
10.1.2.6.2 Rest of Asia Pacific: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.6.3 Rest of Asia Pacific: Microcarriers Market, by Product
10.1.2.6.4 Rest of Asia Pacific: Microcarriers Market, by Equipment
10.1.2.6.5 Rest of Asia Pacific: Microcarriers Market, by Application
10.1.2.6.5.1 Rest of Asia Pacific: Microcarriers Market, by Biopharmaceutical Production
10.1.2.6.6 Rest of Asia Pacific: Microcarriers Market, by End User
11. Microcarriers Market-Industry Landscape
11.1 Overview
11.2 Organic Growth Strategies
11.2.1 Overview
11.3 Inorganic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Teijin Ltd
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Bio-Rad Laboratories Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sartorius AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Danaher Corp
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Corning Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Eppendorf SE
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Asahi Kasei Corp
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Polysciences Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About the Research Team
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Microcarriers Market Segmentation
Table 2. China Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 3. China Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 4. China Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 5. China Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 6. China: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 7. Japan Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 8. Japan Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 9. Japan Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 10. Japan Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 11. Japan: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 12. India Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 13. India Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 14. India Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 15. India Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 16. India: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 17. Australia Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 18. Australia Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 19. Australia Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 20. Australia Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 21. Australia: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 22. South Korea Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 23. South Korea Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 24. South Korea Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 25. South Korea Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 26. South Korea: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 27. Rest of Asia Pacific Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 28. Rest of Asia Pacific Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 29. Rest of Asia Pacific Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 30. Rest of Asia Pacific Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 31. Rest of Asia Pacific: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 32. Recent Organic Growth Strategies in Microcarriers Market
Table 33. Recent Inorganic Growth Strategies in the Microcarriers Market
Table 34. Glossary of Terms
LIST OF FIGURES
Figure 1. Microcarriers Market Segmentation, By Country
Figure 2. Key Insights
Figure 3. Microcarriers Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints for Microcarriers Market
Figure 5. Microcarriers Market Revenue (US$ Mn), 2022 – 2030
Figure 6. Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
Figure 7. Microcarrier Beads: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Media and Reagents: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 10. Bioreactors: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Culture Vessels: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Others: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
Figure 14. Biopharmaceutical Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Therapeutic Protein Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Vaccine Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Cell and Gene Therapy: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Tissue Engineering and Regenerative Medicine: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Asia Pacific Microcarriers Market Share by End User – 2022 & 2030 (%)
Figure 21. Pharmaceutical and Biotechnology Companies: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
Figure 22. Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
Figure 23. Academic and Research Institutes: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
Figure 24. Microcarriers Market, 2022 (US$Mn)
Figure 25. Asia Pacific: Microcarriers Market, By Countries, 2022 And 2030 (%)
Figure 26. China: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Japan: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. India: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Australia: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. South Korea: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 31. Rest of Asia Pacific: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
The List of Companies – Asia Pacific Microcarriers Market
1. Teijin Ltd
2. Bio-Rad Laboratories Inc
3. Sartorius AG
4. Danaher Corp
5. Corning Inc
6. Eppendorf SE
7. Asahi Kasei Corp
8. Polysciences Inc
You must be logged in to post a review.
Reviews
There are no reviews yet.